Vicarious Surgical (NYSE:RBOT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Vicarious Surgical (NYSE:RBOT) to a sell rating in a research report sent to investors on Saturday morning.

Separately, Piper Sandler dropped their price target on Vicarious Surgical from $8.50 to $7.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 13th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Vicarious Surgical has an average rating of “Hold” and an average target price of $7.00.

Vicarious Surgical Stock Performance

Shares of NYSE RBOT opened at $5.85 on Friday. Vicarious Surgical has a fifty-two week low of $5.00 and a fifty-two week high of $19.00. The firm has a market capitalization of $34.69 million, a PE ratio of -0.58 and a beta of 1.40. The stock’s 50-day simple moving average is $8.05 and its 200-day simple moving average is $7.68.

Vicarious Surgical (NYSE:RBOT) last issued its earnings results on Tuesday, August 12th. The company reported ($2.23) earnings per share for the quarter, topping the consensus estimate of ($2.61) by $0.38. On average, sell-side analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Institutional Trading of Vicarious Surgical

An institutional investor recently raised its position in Vicarious Surgical stock. DDD Partners LLC lifted its holdings in Vicarious Surgical Inc. (NYSE:RBOT) by 15.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 213,824 shares of the company’s stock after buying an additional 28,357 shares during the quarter. DDD Partners LLC owned 3.61% of Vicarious Surgical worth $1,403,000 as of its most recent SEC filing. 47.27% of the stock is currently owned by institutional investors.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.